Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments

Clinical and Experimental Immunology

Volumn 111, Issue 3, 1998, Pages 583-587

  Ramisse, F ^a   Deramoudt, F X ^e   Szatanik, M ^b   Bianchi, A ^c   Binder, P ^d   Hannoun, C ^b   Alonso, J M ^c  

^a CENTRE D ETUDES DU BOUCHET   (France)

^b INSTITUT PASTEUR   (France)

^c INSTITUT ALFRED FOURNIER   (France)

^d ONDEO Services   (France)

^e Virbac SA   (France)

Author keywords

Immunoprophylaxis; Influenza A virus pneumonia; Mouse model

Indexed keywords

HEMAGGLUTININ; IMMUNOGLOBULIN F(AB) FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; EARLY DIAGNOSIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; INFLUENZA; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ANIMALS; CHICK EMBRYO; DOGS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL;

EID: 0031948292     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00538.x     Document Type: Article

References (18)

1. Doherty PC, Allen W, Eichelherger M. Roles of αβ and γδ T cell subsets in viral immunity. Annu Rev Immunol 1992; 10:123-51.
2. Bot A, Reichlin A, Isobe H. Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice. J Virol 1996; 70:5668-72.
3. Virelizier JL, Allison AC, Schild GC. Immune responses to influenza virus in the mouse and their role in control of the infection. Brit Med Bull 1979; 35:65-68.
4. Scherle PA, Palladino G. Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol 1992; 148:212-7.
5. + cytolytic T cell responses. J Exp Med 1995; 182:1663-71.
6. Palladino G, Mozdzanowska K, Washko G. Virus neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol 1995; 69:2075-81.
7. Tamura SI, Funato H, Hirabayashi Y. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur J Immunol 1991; 21:1337-44.
8. Stiehm ER. New uses for intravenous immune globulin. N Engl J Med 1991; 325:123-5.
9. Casadevall A, Scharff MD. Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis 1995; 21:150-61.
10. Ramisse F, Szatanik M, Binder P, Alonso JM. Passive local immunotherapy of experimental staphylococcal pneumonia with human intravenous immunoglobulins. J Infect Dis 1993; 168:1030-3.
11. Ottolini MG, Hemming VG, Piazza F. Topical immunoglobulin is an effective therapy for parainfluenza type 3 in a cotton rat model. J Infect Dis 1995; 172:243-5.
12. 2 fragments administered intranasally. J Infect Dis 1996; 173:1123-8.
13. IUIS/WHO notice. Appropriate use of human immunoglobulin in clinical pratice. Clin Exp Immunol 1983; 52:417-22.
14. Kendal AP, Dowdle WR. Influenza virus In: Rose NR, Friedman H, Fahey JL, eds. Manual of clinical laboratory immunology. Washington, DC: American Society for Microbiology, 1986:515-20.
15. Deramoudt FX, Guard C, Lepine N, Alonso JM, Romet-Lemonne JL. Bispecific anti-human red blood Rhesus-D antigen x anti-FcγRI targeted antibody-dependent cell-mediated cytotoxicity and phagocytosis by mononudear leucocytes. Clin Exp Immunol 1992; 89:310-4.
16. WHO. Influenza in the World, 1 October 1994-30 September 1995. Overview. Wkly Epidemiol Rec 1996; 71:1-8.
17. Mazanec MB, Coudret CL, Fletcher DR. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 1995; 69:1339-43.
18. Outlaw MC, Dimmock NJ. IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells. Virol 1993; 195:413-21.